字号·· | 护眼
法国24新闻台

肺癌治疗取得“惊人进展”:免疫疗法延长生存期,mRNA疫苗带来希望‘Amazing progress’ in lung cancer: Immunotherapy extends survival as mRNA vaccines offer hope

点「原文对照」整页切到原文,或双击某段只看那段的原文。

François Picard 很高兴欢迎伦敦大学学院医学肿瘤学教授、肺癌专家 Siow-Ming Lee。

François Picard is pleased to welcome Siow-Ming Lee, Professor of Medical Oncology at the University College London and a specialist in lung cancer.

“肺癌并非单一疾病,而是多种不同类型的癌症,”Lee 解释道。

“Lung cancer is not one cancer. There are many different types of lung cancer,” explains Lee.

几十年来,肺癌一直与吸烟、晚期诊断和较差的生存前景紧密相关。

For decades, lung cancer has been closely associated with smoking, late diagnosis and poor survival prospects.

然而,一场更广泛的癌症革命正在悄然发生:分子肿瘤学、微创手术和免疫疗法的医学进步,正在从根本上改变人们对这种疾病的理解和治疗方式,甚至包括那些从未吸烟的患者。

Yet there is a broader revolution in cancer brewing: Medicine advances in molecular oncology, minimally invasive surgery and immunotherapy are fundamentally transforming both the understanding and treatment of the disease, including among patients who have never smoked.